• Blog Post

Webinar: What Providers Need to Know: New Medication Options in Behavioral Health

Jul 6th, 2021

Behavioral Drug Approvals in 2020

The FDA’s Center for Drug Evaluation and Research approved 53 new drugs in 2020 alone, including several novel treatments for schizophrenia and other behavioral health conditions. What do providers need to know about these new medications?

Genoa Healthcare’s Chief Procurement Officer Stephanie Kornechuk, PharmD, recently hosted a webinar in which she addressed new behavioral drugs and their unique attributes. To learn more, watch the webinar, which:

  • Reviews 2020 behavioral drug approvals
  • Looks ahead at coming drug trends
  • Covers recent policy changes impacting treatment of opioid use disorder
  • Touches on recent COVID-19 vaccine developments

To learn more about how Genoa can help you and those you serve, contact us today.

Recent Posts

  • Blog Post
Genoa Pharmacist faces winter snowstorm to deliver consumers’ medications

When Watertown, New York, Pharmacist Meredith Sullivan made the call to close her pharmacy in preparation for an incoming snowstorm on Friday, Dec. 23, she wondered how the pharmacy’s closure...

  • Pharmacy Openings
Announcing three new pharmacy openings!

We’re excited to announce the opening of three pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...

  • Clinical Insights
Frequently asked questions: buprenorphine-containing products

Information and sources on buprenorphine-containing products were taken from www.sublocade.com and www.suboxone.com.

  • Clinical Insights
What’s on the horizon: four emerging trends in the medication-assisted treatment space

1X-Waiver no longer need to treat opioid use disorder. (2023, January 13). ACEP. 2. Sublocade. 3.BMC launces app to help providers treat patients with opioid use disorder. (2021, March 22)....